<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-06-07" modified="2018-01-31" version="160">
<accession>Q96T88</accession>
<accession>A0JBR2</accession>
<accession>A8K024</accession>
<accession>B2RBA9</accession>
<accession>Q2HIX7</accession>
<accession>Q8J022</accession>
<accession>Q9H6S6</accession>
<accession>Q9P115</accession>
<accession>Q9P1U7</accession>
<name>UHRF1_HUMAN</name>
<protein>
<recommendedName>
<fullName>E3 ubiquitin-protein ligase UHRF1</fullName>
<ecNumber>2.3.2.27</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Inverted CCAAT box-binding protein of 90 kDa</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear protein 95</fullName>
</alternativeName>
<alternativeName>
<fullName>Nuclear zinc finger protein Np95</fullName>
<shortName>HuNp95</shortName>
<shortName>hNp95</shortName>
</alternativeName>
<alternativeName>
<fullName>RING finger protein 106</fullName>
</alternativeName>
<alternativeName>
<fullName>RING-type E3 ubiquitin transferase UHRF1</fullName>
</alternativeName>
<alternativeName>
<fullName>Transcription factor ICBP90</fullName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-like PHD and RING finger domain-containing protein 1</fullName>
<shortName>hUHRF1</shortName>
</alternativeName>
<alternativeName>
<fullName>Ubiquitin-like-containing PHD and RING finger domains protein 1</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">UHRF1</name>
<name type="synonym">ICBP90</name>
<name type="synonym">NP95</name>
<name type="synonym">RNF106</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2000" name="Cancer Res." volume="60" first="121" last="128">
<title>ICBP90, a novel human CCAAT binding protein, involved in the regulation of topoisomerase IIa expression.</title>
<authorList>
<person name="Hopfner R."/>
<person name="Mousli M."/>
<person name="Jeltsch J.-M."/>
<person name="Voulgaris A."/>
<person name="Lutz Y."/>
<person name="Marin C."/>
<person name="Bellocq J.-P."/>
<person name="Oudet P."/>
<person name="Bronner C."/>
</authorList>
<dbReference type="PubMed" id="10646863"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DNA-BINDING</scope>
<scope>INDUCTION</scope>
<scope>FUNCTION</scope>
<source>
<tissue>Thymus</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2006" name="Radiat. Res." volume="166" first="723" last="733">
<title>Isolation and characterization of a novel human radiosusceptibility gene, NP95.</title>
<authorList>
<person name="Muto M."/>
<person name="Fujimori A."/>
<person name="Nenoi M."/>
<person name="Daino K."/>
<person name="Matsuda Y."/>
<person name="Kuroiwa A."/>
<person name="Kubo E."/>
<person name="Kanari Y."/>
<person name="Utsuno M."/>
<person name="Tsuji H."/>
<person name="Ukai H."/>
<person name="Mita K."/>
<person name="Takahagi M."/>
<person name="Tatsumi K."/>
</authorList>
<dbReference type="PubMed" id="17067204"/>
<dbReference type="DOI" id="10.1667/RR0459.1"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="3">
<citation type="submission" date="2000-06" db="EMBL/GenBank/DDBJ databases">
<title>LMO2-induced T cell leukemias overexpress Np95, a gene containing RING and PHD zinc fingers and an ubiquitin-like domain.</title>
<authorList>
<person name="Davenport J.W."/>
<person name="Fernandes E.R."/>
<person name="Neale G.A.M."/>
<person name="Goorha R.M."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<scope>VARIANTS LYS-379 AND THR-638</scope>
</reference>
<reference key="6">
<citation type="submission" date="2004-10" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS HIS-240; LYS-379; THR-638; MET-642 AND PHE-713</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nature" volume="428" first="529" last="535">
<title>The DNA sequence and biology of human chromosome 19.</title>
<authorList>
<person name="Grimwood J."/>
<person name="Gordon L.A."/>
<person name="Olsen A.S."/>
<person name="Terry A."/>
<person name="Schmutz J."/>
<person name="Lamerdin J.E."/>
<person name="Hellsten U."/>
<person name="Goodstein D."/>
<person name="Couronne O."/>
<person name="Tran-Gyamfi M."/>
<person name="Aerts A."/>
<person name="Altherr M."/>
<person name="Ashworth L."/>
<person name="Bajorek E."/>
<person name="Black S."/>
<person name="Branscomb E."/>
<person name="Caenepeel S."/>
<person name="Carrano A.V."/>
<person name="Caoile C."/>
<person name="Chan Y.M."/>
<person name="Christensen M."/>
<person name="Cleland C.A."/>
<person name="Copeland A."/>
<person name="Dalin E."/>
<person name="Dehal P."/>
<person name="Denys M."/>
<person name="Detter J.C."/>
<person name="Escobar J."/>
<person name="Flowers D."/>
<person name="Fotopulos D."/>
<person name="Garcia C."/>
<person name="Georgescu A.M."/>
<person name="Glavina T."/>
<person name="Gomez M."/>
<person name="Gonzales E."/>
<person name="Groza M."/>
<person name="Hammon N."/>
<person name="Hawkins T."/>
<person name="Haydu L."/>
<person name="Ho I."/>
<person name="Huang W."/>
<person name="Israni S."/>
<person name="Jett J."/>
<person name="Kadner K."/>
<person name="Kimball H."/>
<person name="Kobayashi A."/>
<person name="Larionov V."/>
<person name="Leem S.-H."/>
<person name="Lopez F."/>
<person name="Lou Y."/>
<person name="Lowry S."/>
<person name="Malfatti S."/>
<person name="Martinez D."/>
<person name="McCready P.M."/>
<person name="Medina C."/>
<person name="Morgan J."/>
<person name="Nelson K."/>
<person name="Nolan M."/>
<person name="Ovcharenko I."/>
<person name="Pitluck S."/>
<person name="Pollard M."/>
<person name="Popkie A.P."/>
<person name="Predki P."/>
<person name="Quan G."/>
<person name="Ramirez L."/>
<person name="Rash S."/>
<person name="Retterer J."/>
<person name="Rodriguez A."/>
<person name="Rogers S."/>
<person name="Salamov A."/>
<person name="Salazar A."/>
<person name="She X."/>
<person name="Smith D."/>
<person name="Slezak T."/>
<person name="Solovyev V."/>
<person name="Thayer N."/>
<person name="Tice H."/>
<person name="Tsai M."/>
<person name="Ustaszewska A."/>
<person name="Vo N."/>
<person name="Wagner M."/>
<person name="Wheeler J."/>
<person name="Wu K."/>
<person name="Xie G."/>
<person name="Yang J."/>
<person name="Dubchak I."/>
<person name="Furey T.S."/>
<person name="DeJong P."/>
<person name="Dickson M."/>
<person name="Gordon D."/>
<person name="Eichler E.E."/>
<person name="Pennacchio L.A."/>
<person name="Richardson P."/>
<person name="Stubbs L."/>
<person name="Rokhsar D.S."/>
<person name="Myers R.M."/>
<person name="Rubin E.M."/>
<person name="Lucas S.M."/>
</authorList>
<dbReference type="PubMed" id="15057824"/>
<dbReference type="DOI" id="10.1038/nature02399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2003" name="Br. J. Cancer" volume="89" first="120" last="127">
<title>ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.</title>
<authorList>
<person name="Mousli M."/>
<person name="Hopfner R."/>
<person name="Abbady A.-Q."/>
<person name="Monte D."/>
<person name="Jeanblanc M."/>
<person name="Oudet P."/>
<person name="Louis B."/>
<person name="Bronner C."/>
</authorList>
<dbReference type="PubMed" id="12838312"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6601068"/>
</citation>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2004" name="Biochem. Biophys. Res. Commun." volume="319" first="590" last="595">
<title>Phosphorylation of ICBP90 by protein kinase A enhances topoisomerase IIalpha expression.</title>
<authorList>
<person name="Trotzier M.-A."/>
<person name="Bronner C."/>
<person name="Bathami K."/>
<person name="Mathieu E."/>
<person name="Abbady A.-Q."/>
<person name="Jeanblanc M."/>
<person name="Muller C.D."/>
<person name="Rochette-Egly C."/>
<person name="Mousli M."/>
</authorList>
<dbReference type="PubMed" id="15178447"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2004.05.028"/>
</citation>
<scope>PHOSPHORYLATION</scope>
<scope>PHOSPHORYLATION AT SER-298</scope>
<scope>MUTAGENESIS OF SER-298; SER-651 AND SER-666</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genes Cells" volume="9" first="131" last="142">
<title>Down-regulation of nuclear protein ICBP90 by p53/p21Cip1/WAF1-dependent DNA-damage checkpoint signals contributes to cell cycle arrest at G1/S transition.</title>
<authorList>
<person name="Arima Y."/>
<person name="Hirota T."/>
<person name="Bronner C."/>
<person name="Mousli M."/>
<person name="Fujiwara T."/>
<person name="Niwa S."/>
<person name="Ishikawa H."/>
<person name="Saya H."/>
</authorList>
<dbReference type="PubMed" id="15009091"/>
<dbReference type="DOI" id="10.1111/j.1356-9597.2004.00710.x"/>
</citation>
<scope>INDUCTION</scope>
<scope>UBIQUITINATION</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Oncogene" volume="23" first="7601" last="7610">
<title>ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.</title>
<authorList>
<person name="Unoki M."/>
<person name="Nishidate T."/>
<person name="Nakamura Y."/>
</authorList>
<dbReference type="PubMed" id="15361834"/>
<dbReference type="DOI" id="10.1038/sj.onc.1208053"/>
</citation>
<scope>FUNCTION</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DNA-BINDING</scope>
<scope>INTERACTION WITH HDAC1 AND UHRF1BP1</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287 AND SER-639</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="15">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-639</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="16">
<citation type="journal article" date="2007" name="Science" volume="317" first="1760" last="1764">
<title>UHRF1 plays a role in maintaining DNA methylation in mammalian cells.</title>
<authorList>
<person name="Bostick M."/>
<person name="Kim J.K."/>
<person name="Esteve P.O."/>
<person name="Clark A."/>
<person name="Pradhan S."/>
<person name="Jacobsen S.E."/>
</authorList>
<dbReference type="PubMed" id="17673620"/>
<dbReference type="DOI" id="10.1126/science.1147939"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH DNMT1</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2008" name="J. Proteome Res." volume="7" first="1346" last="1351">
<title>Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis.</title>
<authorList>
<person name="Cantin G.T."/>
<person name="Yi W."/>
<person name="Lu B."/>
<person name="Park S.K."/>
<person name="Xu T."/>
<person name="Lee J.-D."/>
<person name="Yates J.R. III"/>
</authorList>
<dbReference type="PubMed" id="18220336"/>
<dbReference type="DOI" id="10.1021/pr0705441"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2008" name="Mol. Cell. Biol." volume="28" first="705" last="717">
<title>ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation.</title>
<authorList>
<person name="Karagianni P."/>
<person name="Amazit L."/>
<person name="Qin J."/>
<person name="Wong J."/>
</authorList>
<dbReference type="PubMed" id="17967883"/>
<dbReference type="DOI" id="10.1128/MCB.01598-07"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>AUTOUBIQUITINATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-91 AND SER-707</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2009" name="Br. J. Cancer" volume="101" first="98" last="105">
<title>UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.</title>
<authorList>
<person name="Unoki M."/>
<person name="Kelly J.D."/>
<person name="Neal D.E."/>
<person name="Ponder B.A."/>
<person name="Nakamura Y."/>
<person name="Hamamoto R."/>
</authorList>
<dbReference type="PubMed" id="19491893"/>
<dbReference type="DOI" id="10.1038/sj.bjc.6605123"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2009" name="Nucleic Acids Res." volume="37" first="493" last="505">
<title>UHRF1 binds G9a and participates in p21 transcriptional regulation in mammalian cells.</title>
<authorList>
<person name="Kim J.K."/>
<person name="Esteve P.O."/>
<person name="Jacobsen S.E."/>
<person name="Pradhan S."/>
</authorList>
<dbReference type="PubMed" id="19056828"/>
<dbReference type="DOI" id="10.1093/nar/gkn961"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH EHMT2</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2009" name="Science" volume="325" first="834" last="840">
<title>Lysine acetylation targets protein complexes and co-regulates major cellular functions.</title>
<authorList>
<person name="Choudhary C."/>
<person name="Kumar C."/>
<person name="Gnad F."/>
<person name="Nielsen M.L."/>
<person name="Rehman M."/>
<person name="Walther T.C."/>
<person name="Olsen J.V."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="19608861"/>
<dbReference type="DOI" id="10.1126/science.1175371"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-399 AND LYS-546</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2010" name="Nucleic Acids Res." volume="38" first="1796" last="1804">
<title>The multi-domain protein Np95 connects DNA methylation and histone modification.</title>
<authorList>
<person name="Rottach A."/>
<person name="Frauer C."/>
<person name="Pichler G."/>
<person name="Bonapace I.M."/>
<person name="Spada F."/>
<person name="Leonhardt H."/>
</authorList>
<dbReference type="PubMed" id="20026581"/>
<dbReference type="DOI" id="10.1093/nar/gkp1152"/>
</citation>
<scope>MUTAGENESIS OF TYR-188 AND TYR-191</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-287; SER-639 AND SER-707</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="26">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2011" name="Nucleic Acids Res." volume="39" first="8355" last="8365">
<title>The USP7/Dnmt1 complex stimulates the DNA methylation activity of Dnmt1 and regulates the stability of UHRF1.</title>
<authorList>
<person name="Felle M."/>
<person name="Joppien S."/>
<person name="Nemeth A."/>
<person name="Diermeier S."/>
<person name="Thalhammer V."/>
<person name="Dobner T."/>
<person name="Kremmer E."/>
<person name="Kappler R."/>
<person name="Langst G."/>
</authorList>
<dbReference type="PubMed" id="21745816"/>
<dbReference type="DOI" id="10.1093/nar/gkr528"/>
</citation>
<scope>FUNCTION</scope>
<scope>AUTOUBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP7</scope>
<scope>INTERACTION WITH USP7 AND DNMT1</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E21306" last="E21306">
<title>Recognition of 5-hydroxymethylcytosine by the Uhrf1 SRA domain.</title>
<authorList>
<person name="Frauer C."/>
<person name="Hoffmann T."/>
<person name="Bultmann S."/>
<person name="Casa V."/>
<person name="Cardoso M.C."/>
<person name="Antes I."/>
<person name="Leonhardt H."/>
</authorList>
<dbReference type="PubMed" id="21731699"/>
<dbReference type="DOI" id="10.1371/journal.pone.0021306"/>
</citation>
<scope>HYDROXYMETHYLCYTOSINE-BINDING</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-287 AND SER-651</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-76; SER-91; SER-287; SER-368; SER-639; SER-707 AND SER-709</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="31">
<citation type="journal article" date="2013" name="Oncogene" volume="32" first="3819" last="3828">
<title>The epigenetic regulator UHRF1 promotes ubiquitination-mediated degradation of the tumor-suppressor protein promyelocytic leukemia protein.</title>
<authorList>
<person name="Guan D."/>
<person name="Factor D."/>
<person name="Liu Y."/>
<person name="Wang Z."/>
<person name="Kao H.Y."/>
</authorList>
<dbReference type="PubMed" id="22945642"/>
<dbReference type="DOI" id="10.1038/onc.2012.406"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH PML</scope>
<scope>MUTAGENESIS OF HIS-741</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="5061" last="5072">
<title>UHRF1 coordinates peroxisome proliferator activated receptor gamma (PPARG) epigenetic silencing and mediates colorectal cancer progression.</title>
<authorList>
<person name="Sabatino L."/>
<person name="Fucci A."/>
<person name="Pancione M."/>
<person name="Carafa V."/>
<person name="Nebbioso A."/>
<person name="Pistore C."/>
<person name="Babbio F."/>
<person name="Votino C."/>
<person name="Laudanna C."/>
<person name="Ceccarelli M."/>
<person name="Altucci L."/>
<person name="Bonapace I.M."/>
<person name="Colantuoni V."/>
</authorList>
<dbReference type="PubMed" id="22286757"/>
<dbReference type="DOI" id="10.1038/onc.2012.3"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4878" last="4887">
<title>The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.</title>
<authorList>
<person name="Babbio F."/>
<person name="Pistore C."/>
<person name="Curti L."/>
<person name="Castiglioni I."/>
<person name="Kunderfranco P."/>
<person name="Brino L."/>
<person name="Oudet P."/>
<person name="Seiler R."/>
<person name="Thalman G.N."/>
<person name="Roggero E."/>
<person name="Sarti M."/>
<person name="Pinton S."/>
<person name="Mello-Grand M."/>
<person name="Chiorino G."/>
<person name="Catapano C.V."/>
<person name="Carbone G.M."/>
<person name="Bonapace I.M."/>
</authorList>
<dbReference type="PubMed" id="22330138"/>
<dbReference type="DOI" id="10.1038/onc.2011.641"/>
</citation>
<scope>INVOLVEMENT IN CANCER</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="4828" last="4833">
<title>M phase phosphorylation of the epigenetic regulator UHRF1 regulates its physical association with the deubiquitylase USP7 and stability.</title>
<authorList>
<person name="Ma H."/>
<person name="Chen H."/>
<person name="Guo X."/>
<person name="Wang Z."/>
<person name="Sowa M.E."/>
<person name="Zheng L."/>
<person name="Hu S."/>
<person name="Zeng P."/>
<person name="Guo R."/>
<person name="Diao J."/>
<person name="Lan F."/>
<person name="Harper J.W."/>
<person name="Shi Y.G."/>
<person name="Xu Y."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="22411829"/>
<dbReference type="DOI" id="10.1073/pnas.1116349109"/>
</citation>
<scope>AUTOUBIQUITINATION</scope>
<scope>DEUBIQUITINATION BY USP7</scope>
<scope>INTERACTION WITH USP7</scope>
<scope>PHOSPHORYLATION AT SER-639</scope>
<scope>MUTAGENESIS OF SER-639</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-385; LYS-546 AND LYS-670</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2017" name="Nat. Struct. Mol. Biol." volume="24" first="325" last="336">
<title>Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Lyon D."/>
<person name="Young C."/>
<person name="Jensen L.J."/>
<person name="Vertegaal A.C."/>
<person name="Nielsen M.L."/>
</authorList>
<dbReference type="PubMed" id="28112733"/>
<dbReference type="DOI" id="10.1038/nsmb.3366"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-279 AND LYS-670</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="37">
<citation type="submission" date="2006-01" db="PDB data bank">
<title>Ubiquitin-like domain of human nuclear zinc finger protein NP95.</title>
<authorList>
<consortium name="Structural genomics consortium (SGC)"/>
</authorList>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 1-76</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2008" name="Acta Crystallogr. F" volume="64" first="922" last="925">
<title>Expression, purification, crystallization and preliminary crystallographic study of the SRA domain of the human UHRF1 protein.</title>
<authorList>
<person name="Delagoutte B."/>
<person name="Lallous N."/>
<person name="Birck C."/>
<person name="Oudet P."/>
<person name="Samama J.P."/>
</authorList>
<dbReference type="PubMed" id="18931436"/>
<dbReference type="DOI" id="10.1107/S1744309108027462"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 408-643</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="34490" last="34494">
<title>Structure and hemimethylated CpG binding of the SRA domain from human UHRF1.</title>
<authorList>
<person name="Qian C."/>
<person name="Li S."/>
<person name="Jakoncic J."/>
<person name="Zeng L."/>
<person name="Walsh M.J."/>
<person name="Zhou M.M."/>
</authorList>
<dbReference type="PubMed" id="18945682"/>
<dbReference type="DOI" id="10.1074/jbc.C800169200"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 414-617</scope>
<scope>MUTAGENESIS OF ARG-433; ARG-443; TYR-466 AND ARG-491</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2008" name="Nature" volume="455" first="822" last="825">
<title>Structural basis for recognition of hemi-methylated DNA by the SRA domain of human UHRF1.</title>
<authorList>
<person name="Avvakumov G.V."/>
<person name="Walker J.R."/>
<person name="Xue S."/>
<person name="Li Y."/>
<person name="Duan S."/>
<person name="Bronner C."/>
<person name="Arrowsmith C.H."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="18772889"/>
<dbReference type="DOI" id="10.1038/nature07273"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 414-617 IN COMPLEX WITH HEMIMETHYLATED DNA</scope>
<scope>MUTAGENESIS OF GLY-448; ASN-489 AND ARG-491</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Cell Res." volume="21" first="1374" last="1378">
<title>Crystal structure of PHD domain of UHRF1 and insights into recognition of unmodified histone H3 arginine residue 2.</title>
<authorList>
<person name="Hu L."/>
<person name="Li Z."/>
<person name="Wang P."/>
<person name="Lin Y."/>
<person name="Xu Y."/>
</authorList>
<dbReference type="PubMed" id="21808300"/>
<dbReference type="DOI" id="10.1038/cr.2011.124"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 298-366</scope>
<scope>MUTAGENESIS OF ASP-334 AND ASP-337</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2011" name="Cell Res." volume="21" first="1379" last="1382">
<title>Structural basis for site-specific reading of unmodified R2 of histone H3 tail by UHRF1 PHD finger.</title>
<authorList>
<person name="Wang C."/>
<person name="Shen J."/>
<person name="Yang Z."/>
<person name="Chen P."/>
<person name="Zhao B."/>
<person name="Hu W."/>
<person name="Lan W."/>
<person name="Tong X."/>
<person name="Wu H."/>
<person name="Li G."/>
<person name="Cao C."/>
</authorList>
<dbReference type="PubMed" id="21808299"/>
<dbReference type="DOI" id="10.1038/cr.2011.123"/>
</citation>
<scope>STRUCTURE BY NMR OF 298-366</scope>
<scope>MUTAGENESIS OF ASP-334 AND ASP-337</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2011" name="J. Biol. Chem." volume="286" first="24300" last="24311">
<title>Recognition of multivalent histone states associated with heterochromatin by UHRF1 protein.</title>
<authorList>
<person name="Nady N."/>
<person name="Lemak A."/>
<person name="Walker J.R."/>
<person name="Avvakumov G.V."/>
<person name="Kareta M.S."/>
<person name="Achour M."/>
<person name="Xue S."/>
<person name="Duan S."/>
<person name="Allali-Hassani A."/>
<person name="Zuo X."/>
<person name="Wang Y.X."/>
<person name="Bronner C."/>
<person name="Chedin F."/>
<person name="Arrowsmith C.H."/>
<person name="Dhe-Paganon S."/>
</authorList>
<dbReference type="PubMed" id="21489993"/>
<dbReference type="DOI" id="10.1074/jbc.M111.234104"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 126-285</scope>
<scope>STRUCTURE BY NMR OF 126-285</scope>
<scope>MUTAGENESIS OF ASP-142; ASP-145; PHE-152; GLU-153; TYR-188 AND ASP-190</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2011" name="Mol. Cell" volume="43" first="275" last="284">
<title>PHD finger recognition of unmodified histone H3R2 links UHRF1 to regulation of euchromatic gene expression.</title>
<authorList>
<person name="Rajakumara E."/>
<person name="Wang Z."/>
<person name="Ma H."/>
<person name="Hu L."/>
<person name="Chen H."/>
<person name="Lin Y."/>
<person name="Guo R."/>
<person name="Wu F."/>
<person name="Li H."/>
<person name="Lan F."/>
<person name="Shi Y.G."/>
<person name="Xu Y."/>
<person name="Patel D.J."/>
<person name="Shi Y."/>
</authorList>
<dbReference type="PubMed" id="21777816"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.07.006"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 298-367 IN COMPLEX WITH ZINC AND HISTONE H3 PEPTIDE</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF 334-ASP-GLU-335</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2011" name="PLoS ONE" volume="6" first="E27599" last="E27599">
<title>The PHD finger of human UHRF1 reveals a new subgroup of unmethylated histone H3 tail readers.</title>
<authorList>
<person name="Lallous N."/>
<person name="Legrand P."/>
<person name="McEwen A.G."/>
<person name="Ramon-Maiques S."/>
<person name="Samama J.P."/>
<person name="Birck C."/>
</authorList>
<dbReference type="PubMed" id="22096602"/>
<dbReference type="DOI" id="10.1371/journal.pone.0027599"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 314-367</scope>
<scope>MUTAGENESIS OF GLN-330; ASP-334 AND ASP-337</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2012" name="J. Mol. Biol." volume="415" first="318" last="328">
<title>UHRF1 double tudor domain and the adjacent PHD finger act together to recognize K9me3-containing histone H3 tail.</title>
<authorList>
<person name="Xie S."/>
<person name="Jakoncic J."/>
<person name="Qian C."/>
</authorList>
<dbReference type="PubMed" id="22100450"/>
<dbReference type="DOI" id="10.1016/j.jmb.2011.11.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 299-364 IN COMPLEX WITH HISTONE H3 PEPTIDE</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12950" last="12955">
<title>Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1.</title>
<authorList>
<person name="Arita K."/>
<person name="Isogai S."/>
<person name="Oda T."/>
<person name="Unoki M."/>
<person name="Sugita K."/>
<person name="Sekiyama N."/>
<person name="Kuwata K."/>
<person name="Hamamoto R."/>
<person name="Tochio H."/>
<person name="Sato M."/>
<person name="Ariyoshi M."/>
<person name="Shirakawa M."/>
</authorList>
<dbReference type="PubMed" id="22837395"/>
<dbReference type="DOI" id="10.1073/pnas.1203701109"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 134-367 IN COMPLEX WITH ZINC AND HISTONE H3 PEPTIDE</scope>
<scope>PHOSPHORYLATION AT SER-298</scope>
<scope>MUTAGENESIS OF 295-ARG-ARG-296</scope>
</reference>
<comment type="function">
<text evidence="30 33 35 36 37 40 44 45 52">Multidomain protein that acts as a key epigenetic regulator by bridging DNA methylation and chromatin modification. Specifically recognizes and binds hemimethylated DNA at replication forks via its YDG domain and recruits DNMT1 methyltransferase to ensure faithful propagation of the DNA methylation patterns through DNA replication. In addition to its role in maintenance of DNA methylation, also plays a key role in chromatin modification: through its tudor-like regions and PHD-type zinc fingers, specifically recognizes and binds histone H3 trimethylated at 'Lys-9' (H3K9me3) and unmethylated at 'Arg-2' (H3R2me0), respectively, and recruits chromatin proteins. Enriched in pericentric heterochromatin where it recruits different chromatin modifiers required for this chromatin replication. Also localizes to euchromatic regions where it negatively regulates transcription possibly by impacting DNA methylation and histone modifications. Has E3 ubiquitin-protein ligase activity by mediating the ubiquitination of target proteins such as histone H3 and PML. It is still unclear how E3 ubiquitin-protein ligase activity is related to its role in chromatin in vivo. May be involved in DNA repair.</text>
</comment>
<comment type="catalytic activity">
<text>S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.</text>
</comment>
<comment type="pathway">
<text>Protein modification; protein ubiquitination.</text>
</comment>
<comment type="subunit">
<text evidence="23 35 36 38 40 44 45 49 50 51 52">Interacts with DNMT3A and DNMT3B (By similarity). Interacts with DNMT1; the interaction is direct. Interacts with USP7; leading to its deubiquitination. Interacts with histone H3. Interacts with HDAC1, but not with HDAC2. Interacts with UHRF1BP1. Interacts with PML. Interacts with EHMT2. Binds hemimethylated CpG containing oligonucleotides.</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1548946"/>
<interactant intactId="EBI-719459">
<id>P26358</id>
<label>DNMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1548946"/>
<interactant intactId="EBI-923653">
<id>Q9Y6K1</id>
<label>DNMT3A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-1548946"/>
<interactant intactId="EBI-80125">
<id>Q9UBC3</id>
<label>DNMT3B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29 30 36 37 40 45">Nucleus</location>
</subcellularLocation>
<text>Localizes to replication foci. Enriched in pericentric heterochromatin. Also localizes to euchromatic regions.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q96T88-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q96T88-2</id>
<name>2</name>
<sequence type="described" ref="VSP_044394"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="30 31 35">Expressed in thymus, bone marrow, testis, lung and heart. Overexpressed in breast cancer.</text>
</comment>
<comment type="developmental stage">
<text evidence="30">Expressed in fetal thymus, liver and kidney.</text>
</comment>
<comment type="induction">
<text evidence="30 31 33 35">Up-regulated in proliferating cells, and down-regulated in quiescent cells. Down-regulated upon adriamycin-induced DNA damage, in a p53/TP53 and CDKN1A-dependent way. Induced by E2F1 transcription factor.</text>
</comment>
<comment type="domain">
<text evidence="51">The tudor-like regions specifically recognize and bind histone H3 unmethylated at 'Arg-2' (H3R2me0), while the PHD-type zinc finger specifically recognizes and binds histone H3 trimethylated at 'Lys-9' (H3K9me3). The tudor-like regions simultaneously recognizes H3K9me3 through a conserved aromatic cage in the first tudor-like subdomain and unmodified H3K4 (H3K4me0) within a groove between the tandem subdomains (PubMed:21489993, PubMed:21777816 and PubMed:22100450). The linker region plays a role in the formation of a histone H3-binding hole between the reader modules formed by the tudor-like regions and the PHD-type zinc finger by making extended contacts with the tandem tudor-like regions (PubMed:22837395).</text>
</comment>
<comment type="domain">
<text evidence="36 38 43">The YDG domain (also named SRA domain) specifically recognizes and binds hemimethylated DNA at replication forks (DNA that is only methylated on the mother strand of replicating DNA) (PubMed:17673620). It contains a binding pocket that accommodates the 5-methylcytosine that is flipped out of the duplex DNA. 2 specialized loops reach through the resulting gap in the DNA from both the major and the minor grooves to read the other 3 bases of the CpG duplex. The major groove loop confers both specificity for the CpG dinucleotide and discrimination against methylation of deoxycytidine of the complementary strand (PubMed:18772889). The YDG domain also recognizes and binds 5-hydroxymethylcytosine (5hmC) (PubMed:21731699).</text>
</comment>
<comment type="domain">
<text evidence="23">The RING finger is required for ubiquitin ligase activity.</text>
</comment>
<comment type="PTM">
<text evidence="34 50 51">Phosphorylation at Ser-298 of the linker region decreases the binding to H3K9me3. Phosphorylation at Ser-639 by CDK1 during M phase impairs interaction with USP7, preventing deubiquitination and leading to degradation by the proteasome.</text>
</comment>
<comment type="PTM">
<text evidence="33 37 44 50">Ubiquitinated; which leads to proteasomal degradation. Autoubiquitinated; interaction with USP7 leads to deubiquitination and prevents degradation. Ubiquitination and degradation takes place during M phase, when phosphorylation at Ser-639 prevents intereaction with USP7 and subsequent deubiquitination. Polyubiquitination may be stimulated by DNA damage.</text>
</comment>
<comment type="disease">
<text>Defects in UHRF1 may be a cause of cancers. Overexpressed in many different forms of human cancers, including bladder, breast, cervical, colorectal and prostate cancers, as well as pancreatic adenocarcinomas, rhabdomyosarcomas and gliomas. Plays an important role in the correlation of histone modification and gene silencing in cancer progression. Expression is associated with a poor prognosis in patients with various cancers, suggesting that it participates in cancer progression.</text>
</comment>
<comment type="sequence caution" evidence="55">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="BAB15177" version="1"/>
</conflict>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/uhrf1/"/>
</comment>
<dbReference type="EC" id="2.3.2.27"/>
<dbReference type="EMBL" id="AF129507">
<property type="protein sequence ID" value="AAF28469.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB177623">
<property type="protein sequence ID" value="BAF36719.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB177624">
<property type="protein sequence ID" value="BAF36720.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB075601">
<property type="protein sequence ID" value="BAC20576.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF274048">
<property type="protein sequence ID" value="AAK55744.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF560733">
<property type="protein sequence ID" value="ABQ59043.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK025578">
<property type="protein sequence ID" value="BAB15177.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK289389">
<property type="protein sequence ID" value="BAF82078.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314579">
<property type="protein sequence ID" value="BAG37156.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY787925">
<property type="protein sequence ID" value="AAV40831.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC027319">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC053467">
<property type="protein sequence ID" value="AAF64067.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471139">
<property type="protein sequence ID" value="EAW69187.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC113875">
<property type="protein sequence ID" value="AAI13876.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74262.1">
<molecule id="Q96T88-2"/>
</dbReference>
<dbReference type="CCDS" id="CCDS74263.1">
<molecule id="Q96T88-1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001041666.1">
<molecule id="Q96T88-1"/>
<property type="nucleotide sequence ID" value="NM_001048201.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276979.1">
<molecule id="Q96T88-1"/>
<property type="nucleotide sequence ID" value="NM_001290050.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276980.1">
<molecule id="Q96T88-1"/>
<property type="nucleotide sequence ID" value="NM_001290051.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001276981.1">
<molecule id="Q96T88-1"/>
<property type="nucleotide sequence ID" value="NM_001290052.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_037414.3">
<property type="nucleotide sequence ID" value="NM_013282.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.108106"/>
<dbReference type="PDB" id="2FAZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=1-76"/>
</dbReference>
<dbReference type="PDB" id="2L3R">
<property type="method" value="NMR"/>
<property type="chains" value="A=126-285"/>
</dbReference>
<dbReference type="PDB" id="2LGG">
<property type="method" value="NMR"/>
<property type="chains" value="A=298-366"/>
</dbReference>
<dbReference type="PDB" id="2LGK">
<property type="method" value="NMR"/>
<property type="chains" value="A=298-366"/>
</dbReference>
<dbReference type="PDB" id="2LGL">
<property type="method" value="NMR"/>
<property type="chains" value="A=298-366"/>
</dbReference>
<dbReference type="PDB" id="2PB7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=408-643"/>
</dbReference>
<dbReference type="PDB" id="3ASK">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B/C/D=134-367"/>
</dbReference>
<dbReference type="PDB" id="3ASL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.41"/>
<property type="chains" value="A=298-367"/>
</dbReference>
<dbReference type="PDB" id="3BI7">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=414-617"/>
</dbReference>
<dbReference type="PDB" id="3CLZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.20"/>
<property type="chains" value="A/B/C/D=414-617"/>
</dbReference>
<dbReference type="PDB" id="3DB3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=126-285"/>
</dbReference>
<dbReference type="PDB" id="3DB4">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.40"/>
<property type="chains" value="A=126-285"/>
</dbReference>
<dbReference type="PDB" id="3DWH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=414-617"/>
</dbReference>
<dbReference type="PDB" id="3FL2">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.75"/>
<property type="chains" value="A=672-793"/>
</dbReference>
<dbReference type="PDB" id="3SHB">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=298-366"/>
</dbReference>
<dbReference type="PDB" id="3SOU">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A/B=298-367"/>
</dbReference>
<dbReference type="PDB" id="3SOW">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=298-367"/>
</dbReference>
<dbReference type="PDB" id="3SOX">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.65"/>
<property type="chains" value="A/B=298-367"/>
</dbReference>
<dbReference type="PDB" id="3T6R">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=299-364"/>
</dbReference>
<dbReference type="PDB" id="3ZVY">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A/B=296-367"/>
</dbReference>
<dbReference type="PDB" id="3ZVZ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="B=314-367"/>
</dbReference>
<dbReference type="PDB" id="4GY5">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.96"/>
<property type="chains" value="A/B/C/D=134-366"/>
</dbReference>
<dbReference type="PDB" id="4QQD">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.28"/>
<property type="chains" value="A/B=126-285"/>
</dbReference>
<dbReference type="PDB" id="5C6D">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.29"/>
<property type="chains" value="C/D=634-665"/>
</dbReference>
<dbReference type="PDB" id="5IAY">
<property type="method" value="NMR"/>
<property type="chains" value="A=134-285, B=642-657"/>
</dbReference>
<dbReference type="PDBsum" id="2FAZ"/>
<dbReference type="PDBsum" id="2L3R"/>
<dbReference type="PDBsum" id="2LGG"/>
<dbReference type="PDBsum" id="2LGK"/>
<dbReference type="PDBsum" id="2LGL"/>
<dbReference type="PDBsum" id="2PB7"/>
<dbReference type="PDBsum" id="3ASK"/>
<dbReference type="PDBsum" id="3ASL"/>
<dbReference type="PDBsum" id="3BI7"/>
<dbReference type="PDBsum" id="3CLZ"/>
<dbReference type="PDBsum" id="3DB3"/>
<dbReference type="PDBsum" id="3DB4"/>
<dbReference type="PDBsum" id="3DWH"/>
<dbReference type="PDBsum" id="3FL2"/>
<dbReference type="PDBsum" id="3SHB"/>
<dbReference type="PDBsum" id="3SOU"/>
<dbReference type="PDBsum" id="3SOW"/>
<dbReference type="PDBsum" id="3SOX"/>
<dbReference type="PDBsum" id="3T6R"/>
<dbReference type="PDBsum" id="3ZVY"/>
<dbReference type="PDBsum" id="3ZVZ"/>
<dbReference type="PDBsum" id="4GY5"/>
<dbReference type="PDBsum" id="4QQD"/>
<dbReference type="PDBsum" id="5C6D"/>
<dbReference type="PDBsum" id="5IAY"/>
<dbReference type="ProteinModelPortal" id="Q96T88"/>
<dbReference type="SMR" id="Q96T88"/>
<dbReference type="BioGrid" id="118893">
<property type="interactions" value="77"/>
</dbReference>
<dbReference type="IntAct" id="Q96T88">
<property type="interactions" value="15"/>
</dbReference>
<dbReference type="MINT" id="MINT-2815626"/>
<dbReference type="BindingDB" id="Q96T88"/>
<dbReference type="ChEMBL" id="CHEMBL2424510"/>
<dbReference type="iPTMnet" id="Q96T88"/>
<dbReference type="PhosphoSitePlus" id="Q96T88"/>
<dbReference type="BioMuta" id="UHRF1"/>
<dbReference type="DMDM" id="67462077"/>
<dbReference type="EPD" id="Q96T88"/>
<dbReference type="MaxQB" id="Q96T88"/>
<dbReference type="PeptideAtlas" id="Q96T88"/>
<dbReference type="PRIDE" id="Q96T88"/>
<dbReference type="DNASU" id="29128"/>
<dbReference type="Ensembl" id="ENST00000612630">
<molecule id="Q96T88-1"/>
<property type="protein sequence ID" value="ENSP00000484739"/>
<property type="gene ID" value="ENSG00000276043"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000615884">
<molecule id="Q96T88-1"/>
<property type="protein sequence ID" value="ENSP00000478601"/>
<property type="gene ID" value="ENSG00000276043"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000616255">
<molecule id="Q96T88-1"/>
<property type="protein sequence ID" value="ENSP00000478348"/>
<property type="gene ID" value="ENSG00000276043"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000624301">
<molecule id="Q96T88-1"/>
<property type="protein sequence ID" value="ENSP00000485604"/>
<property type="gene ID" value="ENSG00000276043"/>
</dbReference>
<dbReference type="GeneID" id="29128"/>
<dbReference type="KEGG" id="hsa:29128"/>
<dbReference type="UCSC" id="uc032hkj.2">
<molecule id="Q96T88-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="29128"/>
<dbReference type="DisGeNET" id="29128"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000276043.4"/>
<dbReference type="GeneCards" id="UHRF1"/>
<dbReference type="HGNC" id="HGNC:12556">
<property type="gene designation" value="UHRF1"/>
</dbReference>
<dbReference type="HPA" id="HPA049408"/>
<dbReference type="MIM" id="607990">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q96T88"/>
<dbReference type="OpenTargets" id="ENSG00000276043"/>
<dbReference type="PharmGKB" id="PA37196"/>
<dbReference type="GeneTree" id="ENSGT00390000008296"/>
<dbReference type="HOGENOM" id="HOG000124662"/>
<dbReference type="HOVERGEN" id="HBG059298"/>
<dbReference type="InParanoid" id="Q96T88"/>
<dbReference type="KO" id="K10638"/>
<dbReference type="PhylomeDB" id="Q96T88"/>
<dbReference type="Reactome" id="R-HSA-5334118">
<property type="pathway name" value="DNA methylation"/>
</dbReference>
<dbReference type="SignaLink" id="Q96T88"/>
<dbReference type="SIGNOR" id="Q96T88"/>
<dbReference type="UniPathway" id="UPA00143"/>
<dbReference type="EvolutionaryTrace" id="Q96T88"/>
<dbReference type="GeneWiki" id="UHRF1"/>
<dbReference type="GenomeRNAi" id="29128"/>
<dbReference type="PRO" id="PR:Q96T88"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000276043"/>
<dbReference type="CleanEx" id="HS_UHRF1"/>
<dbReference type="ExpressionAtlas" id="Q96T88">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q96T88">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0000791">
<property type="term" value="C:euchromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000792">
<property type="term" value="C:heterochromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000790">
<property type="term" value="C:nuclear chromatin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005720">
<property type="term" value="C:nuclear heterochromatin"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0016363">
<property type="term" value="C:nuclear matrix"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005657">
<property type="term" value="C:replication fork"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003700">
<property type="term" value="F:DNA binding transcription factor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0044729">
<property type="term" value="F:hemi-methylated DNA-binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042393">
<property type="term" value="F:histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042802">
<property type="term" value="F:identical protein binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008327">
<property type="term" value="F:methyl-CpG binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035064">
<property type="term" value="F:methylated histone binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031493">
<property type="term" value="F:nucleosomal histone binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0000987">
<property type="term" value="F:proximal promoter sequence-specific DNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0061630">
<property type="term" value="F:ubiquitin protein ligase activity"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0004842">
<property type="term" value="F:ubiquitin-protein transferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007049">
<property type="term" value="P:cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0008283">
<property type="term" value="P:cell proliferation"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006281">
<property type="term" value="P:DNA repair"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0010390">
<property type="term" value="P:histone monoubiquitination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0016574">
<property type="term" value="P:histone ubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010216">
<property type="term" value="P:maintenance of DNA methylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032270">
<property type="term" value="P:positive regulation of cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:2000373">
<property type="term" value="P:positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051865">
<property type="term" value="P:protein autoubiquitination"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042787">
<property type="term" value="P:protein ubiquitination involved in ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090308">
<property type="term" value="P:regulation of methylation-dependent chromatin silencing"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.280.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="2.30.30.30">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.40.10">
<property type="match status" value="2"/>
</dbReference>
<dbReference type="InterPro" id="IPR015947">
<property type="entry name" value="PUA-like_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR014722">
<property type="entry name" value="Rib_L2_dom2"/>
</dbReference>
<dbReference type="InterPro" id="IPR036987">
<property type="entry name" value="SRA-YDG_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR003105">
<property type="entry name" value="SRA_YDG"/>
</dbReference>
<dbReference type="InterPro" id="IPR021991">
<property type="entry name" value="TTD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR029071">
<property type="entry name" value="Ubiquitin-like_domsf"/>
</dbReference>
<dbReference type="InterPro" id="IPR000626">
<property type="entry name" value="Ubiquitin_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011011">
<property type="entry name" value="Znf_FYVE_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR001965">
<property type="entry name" value="Znf_PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR019787">
<property type="entry name" value="Znf_PHD-finger"/>
</dbReference>
<dbReference type="InterPro" id="IPR001841">
<property type="entry name" value="Znf_RING"/>
</dbReference>
<dbReference type="InterPro" id="IPR013083">
<property type="entry name" value="Znf_RING/FYVE/PHD"/>
</dbReference>
<dbReference type="InterPro" id="IPR017907">
<property type="entry name" value="Znf_RING_CS"/>
</dbReference>
<dbReference type="Pfam" id="PF00628">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF02182">
<property type="entry name" value="SAD_SRA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF12148">
<property type="entry name" value="TTD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00240">
<property type="entry name" value="ubiquitin"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00249">
<property type="entry name" value="PHD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00184">
<property type="entry name" value="RING"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00466">
<property type="entry name" value="SRA"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00213">
<property type="entry name" value="UBQ"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF54236">
<property type="entry name" value="SSF54236"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF57903">
<property type="entry name" value="SSF57903"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF88697">
<property type="entry name" value="SSF88697"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50053">
<property type="entry name" value="UBIQUITIN_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51015">
<property type="entry name" value="YDG"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS01359">
<property type="entry name" value="ZF_PHD_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50016">
<property type="entry name" value="ZF_PHD_2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00518">
<property type="entry name" value="ZF_RING_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50089">
<property type="entry name" value="ZF_RING_2"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0156">Chromatin regulator</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0227">DNA damage</keyword>
<keyword id="KW-0234">DNA repair</keyword>
<keyword id="KW-0238">DNA-binding</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0678">Repressor</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0833">Ubl conjugation pathway</keyword>
<keyword id="KW-0862">Zinc</keyword>
<keyword id="KW-0863">Zinc-finger</keyword>
<feature type="chain" description="E3 ubiquitin-protein ligase UHRF1" id="PRO_0000056144">
<location>
<begin position="1"/>
<end position="793"/>
</location>
</feature>
<feature type="domain" description="Ubiquitin-like" evidence="28">
<location>
<begin position="1"/>
<end position="78"/>
</location>
</feature>
<feature type="domain" description="YDG" evidence="29">
<location>
<begin position="419"/>
<end position="582"/>
</location>
</feature>
<feature type="zinc finger region" description="PHD-type" evidence="26">
<location>
<begin position="310"/>
<end position="366"/>
</location>
</feature>
<feature type="zinc finger region" description="RING-type" evidence="27">
<location>
<begin position="724"/>
<end position="763"/>
</location>
</feature>
<feature type="region of interest" description="Tudor-like 1">
<location>
<begin position="133"/>
<end position="209"/>
</location>
</feature>
<feature type="region of interest" description="Tudor-like 2">
<location>
<begin position="216"/>
<end position="283"/>
</location>
</feature>
<feature type="region of interest" description="Linker">
<location>
<begin position="296"/>
<end position="301"/>
</location>
</feature>
<feature type="region of interest" description="Histone H3R2me0 binding">
<location>
<begin position="333"/>
<end position="337"/>
</location>
</feature>
<feature type="region of interest" description="Histone H3R2me0 binding">
<location>
<begin position="353"/>
<end position="355"/>
</location>
</feature>
<feature type="region of interest" description="Required to promote base flipping" evidence="23">
<location>
<begin position="445"/>
<end position="446"/>
</location>
</feature>
<feature type="region of interest" description="Methylcytosine binding">
<location>
<begin position="463"/>
<end position="464"/>
</location>
</feature>
<feature type="region of interest" description="Required for formation of a 5-methylcytosine-binding pocket">
<location>
<begin position="466"/>
<end position="469"/>
</location>
</feature>
<feature type="region of interest" description="Required for formation of a 5-methylcytosine-binding pocket">
<location>
<begin position="478"/>
<end position="481"/>
</location>
</feature>
<feature type="binding site" description="Histone H3K4me0">
<location>
<position position="316"/>
</location>
</feature>
<feature type="binding site" description="Histone H3R2me0">
<location>
<position position="327"/>
</location>
</feature>
<feature type="binding site" description="Histone H3R2me0">
<location>
<position position="330"/>
</location>
</feature>
<feature type="binding site" description="Methylcytosine">
<location>
<position position="469"/>
</location>
</feature>
<feature type="site" description="Required to confer preferential recognition of cytosine over thymine">
<location>
<position position="479"/>
</location>
</feature>
<feature type="site" description="Required to discriminate between hemimethylated DNA versus symmetrically methylated DNA">
<location>
<position position="489"/>
</location>
</feature>
<feature type="site" description="Required for affinity and specificity for 5-mCpG sequence">
<location>
<position position="491"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 18 20">
<location>
<position position="76"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 20">
<location>
<position position="91"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="24">
<location>
<position position="95"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="25">
<location>
<position position="165"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="13 14 17 18 19 20">
<location>
<position position="287"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by PKA" evidence="34 51">
<location>
<position position="298"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine" evidence="16">
<location>
<position position="399"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; alternate" evidence="16">
<location>
<position position="546"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK1" evidence="12 13 18 20 50">
<location>
<position position="639"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="19">
<location>
<position position="651"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="15 18 20">
<location>
<position position="707"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="20">
<location>
<position position="709"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="22">
<location>
<position position="279"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="21">
<location>
<position position="385"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="21">
<location>
<position position="546"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2)" evidence="21 22">
<location>
<position position="670"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_044394" evidence="54">
<original>M</original>
<variation>MGVFAVPPLSSDTM</variation>
<location>
<position position="1"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17886098." id="VAR_022554" evidence="53">
<original>D</original>
<variation>H</variation>
<location>
<position position="240"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17885791." id="VAR_022555" evidence="32 53">
<original>E</original>
<variation>K</variation>
<location>
<position position="379"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs2307209." id="VAR_022556" evidence="32 53">
<original>A</original>
<variation>T</variation>
<location>
<position position="638"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17884843." id="VAR_022557" evidence="53">
<original>T</original>
<variation>M</variation>
<location>
<position position="642"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs17883563." id="VAR_022558" evidence="53">
<original>L</original>
<variation>F</variation>
<location>
<position position="713"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3 without affecting the protein folding; when associated with A-153." evidence="42">
<original>D</original>
<variation>A</variation>
<location>
<position position="142"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="42">
<original>D</original>
<variation>A</variation>
<location>
<position position="145"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="42">
<original>F</original>
<variation>A</variation>
<location>
<position position="152"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3 without affecting the protein folding; when associated with A-142." evidence="42">
<original>E</original>
<variation>A</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="41 42">
<original>Y</original>
<variation>A</variation>
<location>
<position position="188"/>
</location>
</feature>
<feature type="mutagenesis site" description="Slightly impaired binding to histone H3." evidence="42">
<original>D</original>
<variation>A</variation>
<location>
<position position="190"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="41">
<original>Y</original>
<variation>A</variation>
<location>
<position position="191"/>
</location>
</feature>
<feature type="mutagenesis site" description="Disrupts the simultaneous binding to H3R2me0 and H3K9me3." evidence="51">
<original>RR</original>
<variation>AA</variation>
<location>
<begin position="295"/>
<end position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Diminishes phosphorylation by PKA." evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="298"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect ability to bind histone H3 peptide." evidence="48">
<original>Q</original>
<variation>A</variation>
<variation>K</variation>
<location>
<position position="330"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes binding to histone H3." evidence="45">
<original>DE</original>
<variation>AA</variation>
<location>
<begin position="334"/>
<end position="335"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="46 47 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="334"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired binding to histone H3." evidence="46 47 48">
<original>D</original>
<variation>A</variation>
<location>
<position position="337"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect ability to bind DNA." evidence="39">
<original>R</original>
<variation>A</variation>
<location>
<position position="433"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased ability to bind DNA." evidence="39">
<original>R</original>
<variation>A</variation>
<location>
<position position="443"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased affinity for DNA." evidence="38">
<original>G</original>
<variation>D</variation>
<location>
<position position="448"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased ability to bind DNA." evidence="39">
<original>Y</original>
<variation>G</variation>
<location>
<position position="466"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes ability to bind hemimethylated DNA.">
<original>D</original>
<variation>G</variation>
<location>
<position position="469"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes specificity to hemimethylated DNA." evidence="38">
<original>N</original>
<variation>A</variation>
<location>
<position position="489"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased binding to methylated DNA but does not affect ability to bind DNA." evidence="38 39">
<original>R</original>
<variation>A</variation>
<location>
<position position="491"/>
</location>
</feature>
<feature type="mutagenesis site" description="Prevents phosphorylation by CDK1 during M phase, leading to increased stability." evidence="50">
<original>S</original>
<variation>A</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="mutagenesis site" description="Mimics phosphorylation; impaired interaction with USP7, leading to decreased stability." evidence="50">
<original>S</original>
<variation>D</variation>
<location>
<position position="639"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by PKA." evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="651"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on in vitro phosphorylation by PKA." evidence="34">
<original>S</original>
<variation>A</variation>
<location>
<position position="666"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes E3 ubiquitin-protein ligase activity." evidence="52">
<original>H</original>
<variation>A</variation>
<location>
<position position="741"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAF82078." ref="5" evidence="55">
<original>K</original>
<variation>E</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAF28469." ref="1" evidence="55">
<original>K</original>
<variation>N</variation>
<location>
<position position="383"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 1; AAF28469." ref="1" evidence="55">
<original>A</original>
<variation>S</variation>
<location>
<position position="457"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; BAF82078." ref="5" evidence="55">
<original>S</original>
<variation>N</variation>
<location>
<position position="675"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="1"/>
<end position="7"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="13"/>
<end position="19"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="25"/>
<end position="36"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="40"/>
<end position="42"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="43"/>
<end position="47"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="58"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="68"/>
<end position="73"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="127"/>
<end position="129"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="140"/>
<end position="144"/>
</location>
</feature>
<feature type="turn" evidence="11">
<location>
<begin position="146"/>
<end position="148"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="151"/>
<end position="161"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="164"/>
<end position="167"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="182"/>
<end position="188"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="192"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="196"/>
<end position="200"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="201"/>
<end position="203"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="204"/>
<end position="206"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="210"/>
<end position="212"/>
</location>
</feature>
<feature type="helix" evidence="11">
<location>
<begin position="214"/>
<end position="216"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="222"/>
<end position="227"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="229"/>
<end position="231"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="237"/>
<end position="248"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="253"/>
<end position="260"/>
</location>
</feature>
<feature type="strand" evidence="11">
<location>
<begin position="262"/>
<end position="272"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="274"/>
<end position="276"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="277"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="283"/>
<end position="286"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="303"/>
<end position="307"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="309"/>
<end position="311"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="314"/>
<end position="316"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="319"/>
<end position="321"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="323"/>
<end position="325"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="327"/>
<end position="329"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="330"/>
<end position="332"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="334"/>
<end position="336"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="339"/>
<end position="341"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="342"/>
<end position="344"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="345"/>
<end position="347"/>
</location>
</feature>
<feature type="strand" evidence="6">
<location>
<begin position="354"/>
<end position="356"/>
</location>
</feature>
<feature type="turn" evidence="6">
<location>
<begin position="361"/>
<end position="363"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="429"/>
<end position="432"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="433"/>
<end position="438"/>
</location>
</feature>
<feature type="turn" evidence="9">
<location>
<begin position="439"/>
<end position="442"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="448"/>
<end position="452"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="453"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="456"/>
<end position="462"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="473"/>
<end position="479"/>
</location>
</feature>
<feature type="turn" evidence="8">
<location>
<begin position="487"/>
<end position="489"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="503"/>
<end position="511"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="512"/>
<end position="514"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="518"/>
<end position="520"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="527"/>
<end position="529"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="533"/>
<end position="538"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="539"/>
<end position="544"/>
</location>
</feature>
<feature type="strand" evidence="8">
<location>
<begin position="546"/>
<end position="548"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="550"/>
<end position="568"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="572"/>
<end position="582"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="592"/>
<end position="601"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="611"/>
<end position="617"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="678"/>
<end position="686"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="688"/>
<end position="690"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="691"/>
<end position="699"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="706"/>
<end position="708"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="710"/>
<end position="721"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="725"/>
<end position="727"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="728"/>
<end position="730"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="732"/>
<end position="736"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="742"/>
<end position="744"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="745"/>
<end position="753"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="760"/>
<end position="762"/>
</location>
</feature>
<feature type="helix" evidence="10">
<location>
<begin position="776"/>
<end position="785"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="787"/>
<end position="792"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2FAZ"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2L3R"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LGG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2LGL"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ASK"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ASL"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3BI7"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3CLZ"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3DWH"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3FL2"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4QQD"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="17081983"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18220336"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19608861"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="21406692"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="28112733"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000250"/>
<evidence key="24" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q7TPK1"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8VDF2"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00146"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00175"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00214"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00358"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10646863"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12838312"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15009091"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15178447"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15361834"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17673620"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17967883"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18772889"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18945682"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19056828"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20026581"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21489993"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21731699"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21745816"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21777816"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21808299"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21808300"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22096602"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22100450"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22411829"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22837395"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22945642"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source ref="6"/>
</evidence>
<evidence key="54" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000305"/>
<sequence length="793" mass="89814" checksum="E65B15657525C89F" modified="2001-12-01" version="1">
MWIQVRTMDGRQTHTVDSLSRLTKVEELRRKIQELFHVEPGLQRLFYRGKQMEDGHTLFD
YEVRLNDTIQLLVRQSLVLPHSTKERDSELSDTDSGCCLGQSESDKSSTHGEAAAETDSR
PADEDMWDETELGLYKVNEYVDARDTNMGAWFEAQVVRVTRKAPSRDEPCSSTSRPALEE
DVIYHVKYDDYPENGVVQMNSRDVRARARTIIKWQDLEVGQVVMLNYNPDNPKERGFWYD
AEISRKRETRTARELYANVVLGDDSLNDCRIIFVDEVFKIERPGEGSPMVDNPMRRKSGP
SCKHCKDDVNRLCRVCACHLCGGRQDPDKQLMCDECDMAFHIYCLDPPLSSVPSEDEWYC
PECRNDASEVVLAGERLRESKKKAKMASATSSSQRDWGKGMACVGRTKECTIVPSNHYGP
IPGIPVGTMWRFRVQVSESGVHRPHVAGIHGRSNDGAYSLVLAGGYEDDVDHGNFFTYTG
SGGRDLSGNKRTAEQSCDQKLTNTNRALALNCFAPINDQEGAEAKDWRSGKPVRVVRNVK
GGKNSKYAPAEGNRYDGIYKVVKYWPEKGKSGFLVWRYLLRRDDDEPGPWTKEGKDRIKK
LGLTMQYPEGYLEALANREREKENSKREEEEQQEGGFASPRTGKGKWKRKSAGGGPSRAG
SPRRTSKKTKVEPYSLTAQQSSLIREDKSNAKLWNEVLASLKDRPASGSPFQLFLSKVEE
TFQCICCQELVFRPITTVCQHNVCKDCLDRSFRAQVFSCPACRYDLGRSYAMQVNQPLQT
VLNQLFPGYGNGR
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>